EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database

Yan Chen, Xinli Li, Dongni Hou, Wenhao Li iD, Zhike Liu iD, Meng Zhang, IokFai Cheang iD, Peng Shen iD, Hongbo Lin, Siyan Zhan iD, Feng Sun, Yuanlin Song

International Journal of Chronic Obstructive Pulmonary Disease · 2025

DOI: 10.2147/copd.s499783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025. Verfasst von Yan Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of Ch…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Muscarinic Antagonists, Adrenergic beta-2 Receptor Agonists, Practice Patterns, Physicians'. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMuscarinic AntagonistsAdrenergic beta-2 Receptor AgonistsPractice Patterns, Physicians'Bronchodilator AgentsAdrenal Cortex HormonesLungHumansRetrospective StudiesMaleFemaleMiddle AgedDatabases, FactualAgedChinaDrug Therapy, CombinationAdministration, InhalationTreatment OutcomeTime FactorsAdultEast Asian People

Stichwörter der Autor:innen

COPDICSLABALAMA

Substanzen

Muscarinic AntagonistsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
  • State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, People's Repu…
  • Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, People's Republic of China.
  • Yinzhou District Centre for Disease Control and Prevention, Ningbo, Zhejiang, People's Republic of China.
  • Shanghai Key Laboratory of Lung Inflammation and Injury, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

ORCID-Profile: Wenhao Li, Zhike Liu, IokFai Cheang, Peng Shen, Siyan Zhan

Zitieren

APA

Chen, Y., Li, X., Hou, D., Li, W., Liu, Z., Zhang, M., Cheang, I., Shen, P., Lin, H., Zhan, S., Sun, F., & Song, Y. (2025). Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s499783

Vancouver

Chen Y, Li X, Hou D, Li W, Liu Z, Zhang M, et al. Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s499783

BibTeX
@article{Chen2025,
  author = {Chen, Yan and Li, Xinli and Hou, Dongni and Li, Wenhao and Liu, Zhike and Zhang, Meng and Cheang, IokFai and Shen, Peng and Lin, Hongbo and Zhan, Siyan and Sun, Feng and Song, Yuanlin},
  title = {Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  doi = {10.2147/copd.s499783}
}
Kostenlos starten →